Past Events

-

Repurposing Off-Patent Drugs: Research & Regulatory Challenges

Join us for an interactive two-day workshop to discuss challenges around repurposing drugs that are already on the market but lack commercial and regulatory incentives for further research and development.

Visit us at DIA Global

DIA 2019 Global Annual Meeting in San Diego

Project Facilitate: Enhancing the Single Patient IND Process for Oncology

May 16, 2019   |   1:00 PM to 3:30 PM FDA White Oak Campus Building 31, Room 1503 - Great Room

2019 Annual Public Meeting

Annual Public Meeting Set for May 2, 2019

Collecting Data from EA Treatment for Regulatory Submissions Presentation

Executive Director June Wasser will present Collecting Data from EA Treatment for Regulatory Submissions at the Life Science Compassionate Access Summit at 4:00 pm, Monday, March 18th in Philadelphia.

2018 Innovations in Regulatory Science Awards Dinner

The Reagan-Udall Foundation for the FDA honored two longtime U.S.

Leveraging Real-World Treatment Experience from EA Protocols

See Event Highlights and Download the Meeting Report 

Expanded Access Programs and Real-World Evidence: Public Meeting

Expanded access programs, sometimes also called “compassionate use” programs, provide patients with serious or immediately life-threatening diseases or conditions access to investigational products outside of clinical tria

The Floridian: Congress Should Press for FDA Reform to Crack Down on Illegal E-Cigarettes

According to findings by the Reagan Udall Foundation, that is exactly what is happening as stakeholders navigating the process “expressed concerns about a lack of clarity, transparency, and communication” regarding the CTP’s priorities and decision-making processes.

2024 Innovations in Regulatory Science Awards

Save the date for the 2024 Innovations in Regulatory Science Awards. Join the Reagan-Udall Foundation for the FDA to celebrate excellence in leadership, scientific breakthroughs, and advocacy in public health.